How is overt hepatic encephalopathy (HE) managed?
It’s important to understand that there are certain risks involved with having overt HE. Ongoing management can help reduce those risks.
Once an episode of overt HE happens, ongoing management is recommended to help reduce the risk of another episode. This is called maintenance therapy.
The focus of maintenance therapy is to reduce the toxins in the body that can lead to additional overt HE episodes. The most commonly prescribed treatments are:
The safety and efficacy of XIFAXAN in HE patients has not been studied for longer than 6 months in clinical trials.
If patients recover a significant amount of liver function, they may be able to discontinue HE therapy.